Updated Jul 16, 2026
Parsons Erin has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Erin Parsons is identified in the SEC filing context as a Director of Kiora Pharmaceuticals, Inc. as of the filing dated 2026-06-12. The available SEC context confirms only her board role at Kiora Pharmaceuticals; no additional biographical details are provided in the filing.
| Role | Director |
|---|---|
| Notability | 40/100 |
Erin Parsons is identified in the SEC filing context as a Director of Kiora Pharmaceuticals, Inc. as of the filing dated 2026-06-12. The available SEC context confirms only her board role at Kiora Pharmaceuticals; no additional biographical details are provided in the filing.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Parsons Erin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.